UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study

International journal of cancer, 2013-03, Vol.132 (6), p.1429-1438

2013

Volltextzugriff (PDF)

Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease

Upsala journal of medical sciences, 2024, Vol.129, p.e10361-9

2024

Volltextzugriff (PDF)

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.376-384

2019

Volltextzugriff (PDF)

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

Arthritis research & therapy, 2020-12, Vol.22 (1), p.288-288, Article 288

2020

Volltextzugriff (PDF)

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.2025-2030

2017

Volltextzugriff (PDF)

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

Rheumatology (Oxford, England), 2019-08, Vol.58 (8), p.1367-1377

2019

Volltextzugriff (PDF)

Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics

Cancer epidemiology, biomarkers & prevention, 2006-11, Vol.15 (11), p.2069-2077

2006

Volltextzugriff (PDF)

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Cancers, 2022-03, Vol.14 (6), p.1509

2022

Volltextzugriff (PDF)

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Acta oncologica, 2017-04, Vol.56 (4), p.599-607

2017

Volltextzugriff (PDF)

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice

International journal of rheumatic diseases, 2019-07, Vol.22 (7), p.1226-1232

2019

Volltextzugriff (PDF)

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X231201047-1759720X231201047

2023

Volltextzugriff (PDF)

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Rheumatic & musculoskeletal diseases open, 2021-12, Vol.7 (3), p.e001987

2021

Volltextzugriff (PDF)

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002776

2022

Volltextzugriff (PDF)

No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

Annals of the rheumatic diseases, 2014-11, Vol.73 (11), p.2061-2062

2014

Volltextzugriff (PDF)

Rheumatoid arthritis and malignant lymphomas

Current opinion in rheumatology, 2004-05, Vol.16 (3), p.254-261

2004

Volltextzugriff (PDF)

Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95

Journal of rheumatology, 2002-05, Vol.29 (5), p.906

2002

Volltextzugriff (PDF)

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.601-610

2023

Volltextzugriff (PDF)

Minor Genetic Overlap Among Rheumatoid Arthritis, Myocardial Infarction, and Myocardial Infarction Risk Determinants

Arthritis & rheumatology (Hoboken, N.J.), 2024-09, Vol.76 (9), p.1344-1352

2024

Volltextzugriff (PDF)

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1363-1368

2011

Volltextzugriff (PDF)

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.189-197

2023

Volltextzugriff (PDF)

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.970-978

2015

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Annals of the rheumatic diseases, 2021-08, Vol.80 (8), p.1086-1093

2021

Volltextzugriff (PDF)

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

Annals of the rheumatic diseases, 2019-03, Vol.78 (3), p.320-327

2019

Volltextzugriff (PDF)

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.105-111

2017

Volltextzugriff (PDF)

Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice

Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.1810-1818

2022

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(137)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(104)
Science & Technology
(104)
Medicin Och Hälsovetenskap
(95)
Humans
(89)
Rheumatology
(76)
Female
(71)
Male
(70)
Middle Aged
(68)
Rheumatoid Arthritis
(55)
Adult
(54)
Aged
(50)
Sweden - Epidemiology
(45)
Biological And Medical Sciences
(37)
Arthritis, Rheumatoid - Drug Therapy
(36)
Medical Sciences
(36)
Risk Factors
(32)
Antirheumatic Agents - Therapeutic Use
(31)
Clinical Medicine
(31)
Klinisk Medicin
(30)
Reumatologi Och Inflammation
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study

Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

Rheumatoid arthritis and malignant lymphomas

Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Minor Genetic Overlap Among Rheumatoid Arthritis, Myocardial Infarction, and Myocardial Infarction Risk Determinants

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice

Suchergebnisse filtern